Each Unit consists of one common share of the
The Company intends to use the proceeds from the Offering toward product development and general operations.
All securities issued in connection with the Offering will be subject to a statutory hold period of four months plus a day from the date of issuance in accordance with applicable securities laws ending on
The securities offered have not been and will not be registered under the United States Securities Act of 1933, as amended (the “
ON BEHALF OF THE BOARD OF DIRECTORS
“Phil Floucault”
Chief Executive Officer and President
About
Isracann is a multidisciplinary cannabis focused producer and product developer with Israeli-based cannabis production farm assets and a Canadian natural health medicine development and production arm. Concurrently focused on initial retail sales in
Contact
+1 (604) 343-2724
info@isracann.com
www.isracann.com
Forward-Looking Information
This release may contain forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words “expects”, “plans”, “anticipates”, “believes”, “intends”, “estimates”, “projects”, “potential” and similar expressions, or that events or conditions “will”, “would”, “may”, “could” or “should” occur. Forward-looking statements may include, without limitation, statements relating to the Company’s plans or goals, the Offering and the proceeds of the Offering. The forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. All forward-looking statements in this press release are made as of the date of this press release. The forward-looking statements contained herein are also subject generally to assumptions and risks and uncertainties that are described from time to time in the Company's documents filed from time to time with the Canadian Securities Exchange, the
The CSE does not accept responsibility for the adequacy or accuracy of this release.
Source:
2022 GlobeNewswire, Inc., source